The technique behind the findings deserves attention in its own right. Unlike conventional magnetic resonance imaging, which maps anatomy, proton magnetic resonance spectroscopy, often abbreviated as ¹H-MRS, measures the chemical composition of living brain tissue. Each metabolite resonates at a characteristic frequency, allowing researchers to quantify molecules such as NAA, creatine, choline and glutamate without a single invasive procedure. NAA occupies a special place in this molecular catalogue. It is produced almost exclusively within neurons and their mitochondria, and decades of research have tied its concentration to neuronal density, mitochondrial metabolism and overall cellular integrity. When NAA drops in a region of the brain, it is generally read as a warning sign that neurons there are struggling, whether through loss of cells, metabolic impairment or both. Conditions as varied as multiple sclerosis, Alzheimer’s disease and diabetes all leave measurable NAA fingerprints.

To assemble the new analysis, the researchers followed the PRISMA reporting guidelines, systematically searching PubMed, Scopus and Embase for studies that had examined the relationship between body mass index and regional brain NAA. After screening, 23 eligible studies made the cut. The team then ran separate random-effects meta-analyses for two kinds of comparisons: categorical contrasts between groups of normal weight and groups with overweight or obesity, and continuous analyses that treated body mass index as a sliding scale correlated against NAA concentrations. They also conducted supplementary pooled analyses across brain regions to generate a brain-wide estimate, and they modeled the results using both lower-bound and upper-bound assumptions to test how robust the overall pattern was to analytical choices.

The headline result concerns the frontal region. Across categorical comparisons, people with higher body mass showed significantly lower frontal NAA, with a standardized effect size of Hedges’ g equal to minus 0.48 and a 95 percent confidence interval running from minus 0.93 to minus 0.03, a statistically significant difference. The continuous analyses told the same story: across all included studies, rising body mass index correlated with falling frontal NAA, with a pooled correlation coefficient of minus 0.218 and a confidence interval of minus 0.323 to minus 0.108, significant at p less than 0.001. In practical terms, the more body mass a person carried, the lower the neuronal health marker measured in the very regions responsible for planning, self-control and higher-order cognition.

Two other regions produced notable signals. In the categorical analysis, the right hippocampal region, a structure central to memory formation and famously vulnerable to metabolic and neurodegenerative disease, showed a significant NAA reduction in people with higher body weight, with Hedges’ g equal to minus 0.51 and a confidence interval of minus 0.84 to minus 0.19. In the continuous analyses, the parietal region emerged as significant, with a correlation of minus 0.256 and a confidence interval of minus 0.463 to minus 0.022. The hippocampal finding echoes earlier work suggesting that overweight is associated with reduced hippocampal NAA, and it dovetails with a broader literature linking obesity to smaller hippocampal volumes and elevated dementia risk.

Perhaps the most consequential result came from the supplementary pooled analyses that collapsed findings across all brain regions. When the team aggregated continuous results using both the lower-bound model, which assumed the most negative associations, and the upper-bound model, which assumed the least negative or most positive ones, the overall negative relationship between body mass index and NAA remained significant in both cases. That kind of consistency across bounding assumptions is a strong robustness check. The categorical pooled analyses, by contrast, retained significance only within the lower-bound model, suggesting that while the overall brain-wide association is convincing in the continuous framework, the strength of group-based contrasts is more sensitive to how studies are combined. The authors conclude that higher body mass index is associated with lower neural NAA most consistently in frontal regions, but that the pooled results point toward more widespread NAA-obesity associations across the brain.

These neurometabolic findings fit into a much larger and increasingly urgent scientific conversation. Neuroimaging studies over the past two decades have documented reduced gray matter volume, thinner frontal cortex and diminished white matter integrity in people with obesity, and large collaborative efforts such as the ENIGMA consortium have confirmed structural brain differences associated with body mass across thousands of participants. Functional imaging has added its own evidence, including reports of reduced prefrontal metabolic activity and decreased prefrontal blood flow in otherwise healthy adults with elevated body mass. Cognitive research has repeatedly linked higher body mass index to executive dysfunction, and longitudinal cohorts have connected midlife obesity to accelerated cognitive decline. What the new meta-analysis adds is a molecular bridge: a measurable chemical correlate of neuronal health that moves the field one step closer to understanding how excess body weight might translate into neural vulnerability.

The mechanistic possibilities are numerous and not mutually exclusive. Mitochondrial dysfunction is a leading candidate, since NAA is synthesized in neuronal mitochondria and its levels track the energy state of cells. Chronic low-grade inflammation, a hallmark of obesity, is known to damage neurons and has been linked to altered brain metabolites in other contexts. Insulin resistance offers another plausible pathway; studies combining spectroscopy with positron emission tomography have found that insulin-stimulated brain glucose uptake correlates with brain metabolites in severe obesity, and reduced insulin sensitivity has been tied to altered neurotransmitter levels. Vascular factors, dyslipidemia and oxidative stress have each been implicated in early neurochemical changes associated with metabolic syndrome. The new meta-analysis cannot adjudicate among these mechanisms, but by establishing a robust regional pattern, it gives future mechanistic studies a concrete target.

There are important caveats. Nearly all of the included studies are cross-sectional, meaning they capture a snapshot in time and cannot establish whether higher body mass causes NAA depletion, whether metabolic brain changes contribute to weight gain, or whether both reflect a third factor. Spectroscopy also faces a technical subtlety specific to this research question: subcutaneous and other fat deposits can influence measured metabolite signal strengths, and methodological work has examined whether superficial fat affects metabolite concentrations determined with water referencing. The authors of the meta-analysis were clearly aware of these measurement challenges, and the consistency of the frontal findings across both categorical and continuous frameworks suggests the signal is not easily explained away. Still, heterogeneity across studies in voxel placement, sequence parameters and quantification methods remains an inherent limitation of pooling spectroscopy data.

Why does this matter beyond the laboratory? If reduced NAA marks early, potentially reversible neuronal metabolic stress, then spectroscopy could serve as a sensitive biomarker for tracking brain health in obesity research, complementing structural imaging and cognitive testing. Intriguingly, one prior study found that intragastric balloon therapy in patients with morbid obesity led to normalization of brain spectroscopic markers associated with diabetes, raising the possibility that metabolic interventions might restore neurometabolic profiles. The Dalhousie team argues that their findings support the utility of proton magnetic resonance spectroscopy as a complementary neuroimaging modality within obesity-related brain research. As obesity rates continue to climb worldwide and the search intensifies for early indicators of brain vulnerability, a non-invasive window into neuronal chemistry may prove to be exactly the tool the field has been waiting for.

Subject of Research: The association between body mass index and regional brain N-acetylaspartate concentrations measured with proton magnetic resonance spectroscopy

Article Title: Body mass index and regional brain N-acetylaspartate: a systematic review and meta-analysis of ¹H-MRS studies

Article References: MacGillivray, C., Wu, L., Fraiha-Pegado, J., McWhinney, S., & Hajek, T. (2026). Body mass index and regional brain N-acetylaspartate: a systematic review and meta-analysis of ¹H-MRS studies. International Journal of Obesity. https://doi.org/10.1038/s41366-026-02214-z

Image Credits: AI Generated

DOI: 10.1038/s41366-026-02214-z

Keywords: obesity, body mass index, N-acetylaspartate, magnetic resonance spectroscopy, neurometabolism, frontal lobe, hippocampus, neuronal integrity, meta-analysis, brain health, mitochondrial metabolism, neuroimaging